| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |